Gabe represents a wide range of healthcare industry clients, including institutional acute and post-acute providers such as health systems, hospitals, rehabilitation facilities, home health agencies, hospices, nursing homes, and senior living facilities, as well as ancillary providers such as laboratories, pharmacies, medical device manufacturers, diagnostic testing facilities, durable medical equipment suppliers, and sleep centers. He also represents practitioner-led organizations such as physician-owned hospitals, physician groups, therapy practices, and telemedicine providers.  As a result of this diversified practice, his proficiency extends to federal and state regulatory compliance matters, Medicare and Medicaid reimbursement and enrollment, and fraud and abuse laws (including the Anti-Kickback Statute, Stark Law, EKRA, and similar state laws).

On the transactional side, Gabe regularly works with clients across the country on some of the largest and most significant healthcare provider transactions.  He maintains extensive relationships with state healthcare regulatory agencies and is well versed in the sub regulatory state licensure policies and processes. His recent transactional work includes advising healthcare providers and investors, including private capital, on key regulatory issues impacting healthcare transactions, such as: 

• Transaction evaluation and structuring, including asset and equity purchases, non-profit member substitutions, mergers, internal reorganizations, joint ventures, affiliations, and other contracting and alignment initiatives
• Corporate practice of medicine and fee-splitting compliance, including national and regional PC/MSO models
• Medicare and Medicaid change of ownership (CHOW) and change of information (COI) enrollment filings
• Material change transaction notices to state attorneys general
• Licensure, permit and accreditation filings
• Transaction due diligence

Prior to entering private practice, Gabriel worked at the Centers for Medicare and Medicaid Services (CMS), first in the Center for Medicare and Medicaid Innovation (CMMI), where he focused on the development of value-based payment models, and later in the CMS Division of Technical Payment Policy, which administers the Stark Law. He led multidisciplinary teams through the federal rulemaking process and collaborated with the U.S. Department of Health and Human Services Office of Inspector General on the design of fraud and abuse waivers for CMS alternative payment models.